New sedative could make medical procedures safer for frail patients
NCT ID NCT07362173
First seen Jan 25, 2026 · Last updated May 13, 2026 · Updated 12 times
Summary
This study tests a new, fast-acting sedative called remimazolam in 200 elderly or seriously ill patients undergoing medical procedures. The goal is to see if it provides safer sedation with fewer side effects like low blood pressure or breathing problems compared to standard sedatives. The findings may help develop better sedation protocols for high-risk patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD III/IV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Regional Institute of Gastroenterology-Hepatology Prof. Dr. Octavian Fodor
Cluj-Napoca, Cluj, Romania
Conditions
Explore the condition pages connected to this study.